RegCell Co.,Ltd.

RegCell is a university-originated venture company. RegCell aims to generate novel immunotherapies with two prominent scientists, Prof. Shimon Sakaguchi and Prof. Hiroshi Kawamoto. In particular, we focus the roles of T-cells and try to control antigen-specific T-cell function.